Home Ocuphire

Ocuphire

In operation
IPO
Small Molecule Drug Research and Development, Manufacturer

Basic Information

Ocuphire, headquartered in Michigan, USA, is a novel biotechnology company. Ocuphire is committed to the development and commercialization of small-molecule drugs to address unmet medical needs in the field of ocular diseases and seeks strategic partners for global commercialization.
Ocuphire Pharma, Inc.
Detroit,Michigan,United States of America
less than 15 people
February 01, 2018
admin@ocuphire.com